Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection with Borderline Vascularity: an Important Consideration of Timing of Revascularization

NCT05553509 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT05553509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05553509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Outcomes Following Surgical Debridement of Diabetic Foot Infection with Borderline Vascularity: an Important Consideration of Timing of Revascularization
Lead sponsor
Assiut University
Phase
Observational
Overall status
Active, not recruiting
Start date
January 1, 2023
Completion date
September 1, 2025
Enrollment
70 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic limb threatening ischemia